Mutant p53 as a Regulator and Target of Autophagy
One of the most notoriously altered genes in human cancer is the tumor-suppressor TP53, which is mutated with high frequency in more cancers than any other tumor suppressor gene. Beyond the loss of wild-type p53 functions, mutations in the TP53 gene often lead to the expression of full-length protei...
Main Authors: | Yong Shi, Erik Norberg, Helin Vakifahmetoglu-Norberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.607149/full |
Similar Items
-
Triangular Relationship between p53, Autophagy, and Chemotherapy Resistance
by: Jingwen Xu, et al.
Published: (2020-11-01) -
Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
by: Shengliang Zhang, et al.
Published: (2022-04-01) -
Butein inhibits cancer cell growth by rescuing the wild-type thermal stability of mutant p53
by: Bin Song, et al.
Published: (2023-07-01) -
Targeting Mutant p53 for Cancer Treatment: Moving Closer to Clinical Use?
by: Michael J. Duffy, et al.
Published: (2022-09-01) -
Amentoflavone Induces Autophagy And Modulates P53
by: Moon-Moo Kim
Published: (2018-12-01)